Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.01-21 Metastatic Lung Carcinoma —An Institutional Experience From Eastern India

Journal of Thoracic Oncology

English

P1.01-68 Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 Status With Outcomes for Immune Checkpoint Inhibitors in Advanced NSCLC Patients

Journal of Thoracic Oncology

English

P3.13-11 Advanced NSCLC Treated With Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study

Journal of Thoracic Oncology

English

Recurrent Pneumonitis Induced by Atezolizumab (Anti–Programmed Death Ligand 1) in NSCLC Patients Who Previously Experienced Anti-Programmed Death 1 Immunotherapy-Related Pneumonitis

Journal of Thoracic Oncology

English

P3.15-18 Comparison of Pain Control Effects and Side Effects Early After VATs Lobectomy Between IV-PCA, Epidural-Pca and On-Q

Journal of Thoracic Oncology

English

P1.03-26 Analysis of DDR2 Gene Aberrations in Chinese Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis

Journal of Thoracic Oncology

English

P1.16-11 Monitoring of Early Stage Lung Cancer Using Liquid Biopsies

Journal of Thoracic Oncology

English

Predicting Malignancy Risk of Screen Detected Lung Nodules – Mean Diameter or Volume

Journal of Thoracic Oncology

English

P2.10-16 Finding the Relations Between Lung Cancer and Associated Risk Factors in Pakistani Population

Journal of Thoracic Oncology

English

OA08.03 Phase II Trial of Pembrolizumab (NCT02399371) in Previously-Treated Malignant Mesothelioma (MM): Final Analysis

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Pulmonary

P3.01-21 Metastatic Lung Carcinoma —An Institutional Experience From Eastern India

P1.01-68 Correlation of the Lung Immune Prognostic Index (LIPI) and PDL1 Status With Outcomes for Immune Checkpoint Inhibitors in Advanced NSCLC Patients

P3.13-11 Advanced NSCLC Treated With Gefitinib or Erlotinib for Five Years or Longer - Retrospective Slovakian Study

Recurrent Pneumonitis Induced by Atezolizumab (Anti–Programmed Death Ligand 1) in NSCLC Patients Who Previously Experienced Anti-Programmed Death 1 Immunotherapy-Related Pneumonitis

P3.15-18 Comparison of Pain Control Effects and Side Effects Early After VATs Lobectomy Between IV-PCA, Epidural-Pca and On-Q

P1.03-26 Analysis of DDR2 Gene Aberrations in Chinese Non-Small-Cell Lung Cancer Patients and Evaluation of Their Prognosis

P1.16-11 Monitoring of Early Stage Lung Cancer Using Liquid Biopsies

Predicting Malignancy Risk of Screen Detected Lung Nodules – Mean Diameter or Volume

P2.10-16 Finding the Relations Between Lung Cancer and Associated Risk Factors in Pakistani Population

OA08.03 Phase II Trial of Pembrolizumab (NCT02399371) in Previously-Treated Malignant Mesothelioma (MM): Final Analysis